Cannabis companies say DEA has closed mind against a less-dangerous pot ranking
Advocates accuse Drug Enforcement Administration of blocking the reclassification of cannabis as a Schedule III drug under the Controlled Substances Act.
Cannabis and Trump 2.0: 2025 and beyond
Alexander Malyshev and Sarah Ganley of Carter Ledyard & Milburn LLP discuss what the cannabis sector can expect as 2025 ...
MJBizDaily2d
Colorado shut out of marijuana rescheduling hearings by ‘biased’ DEA, filing alleges
The DEA rejected a September request from Colorado officials to participate in the United States' historic marijuana ...
Cannabis/Beer Company Tilray Outlines Plan To Reduce Its Beverage Portfolio, Reports Mixed Q2 Earnings
Tilray Brands reported 9% YoY revenue growth in Q2 2025 to $210.95 million. Fiscal 2025 guidance remains strong at $950 ...
cannabiswire1d
Motion Filed to Remove “Biased” DEA Ahead of Cannabis Rescheduling Hearings
A group of pro-cannabis entities scheduled to present in the forthcoming cannabis rescheduling hearing have filed a new ...
greenmarketreport7d
US cannabis industry poised for more changes in 2025
Despite legalization disappointments from 2024, the cannabis industry is far from standing still as the calendar changes over ...
Amplify To Liquidate Cannabis-Focused MJUS ETF As Regulatory Uncertainty Weighs On Sector
Amplify ETFs plans to liquidate MJUS, a cannabis-related ETF, due to regulatory issues. Other cannabis ETFs also struggling ...
Marijuana Moment2d
DEA Judge Orders Agency To Respond To New Allegations It Opposes Marijuana Rescheduling And Improperly Conspired With Prohibitionists
A Drug Enforcement Administration (DEA) judge has ordered the agency to respond to new allegations that it opposes the Biden ...